FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to peptides inhibiting mucin hypersecretion. The peptides have an amino acid sequence containing up to 24 amino acid residues of the sequence GAQFSKTAAKGEAAAERPGEAAVA which can have at least one amino acid substitute in said sequence selected from a group consisting of the substitute of A by K, the substitute of F, K, G, Q, S, T and/or E for A; or the substitute of Q for E.
EFFECT: preparation of a pharmaceutical composition on the basis of the peptides for mucin hypersecretion inhibition.
28 cl, 9 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS OF DEPRESSING INFLAMMATION MEDIATOR RELEASE AND PEPTIDES APPLIED FOR THIS PURPOSE | 2007 |
|
RU2423376C2 |
| METASTASIS INHIBITORS | 2014 |
|
RU2681213C2 |
| METHODS OF REGULATING INFLAMMATION MEDIATORS AND PEPTIDES USED IN THEM | 2007 |
|
RU2429004C2 |
| GLUCAGON ANALOGUES, POSSESSING HIGHER SOLUBILITY AND STABILITY IN BUFFERS WITH PHYSIOLOGICAL Ph VALUES | 2009 |
|
RU2560254C2 |
| NOVEL MOLECULE INHIBITORS OF JNK | 2011 |
|
RU2570417C2 |
| GLUCAGON SUPERFAMILY PEPTIDES EXHIBITING NUCLEAR HORMONE RECEPTOR ACTIVITY | 2011 |
|
RU2604067C2 |
| SYNTHESIS OF INSULINOTROPIC PEPTIDES | 2007 |
|
RU2448978C2 |
| PRODUCT AND METHOD FOR MUCUS VISCOSITY NORMALIZATION | 2014 |
|
RU2750211C2 |
| PEPTIDE PRO-DRUGS OF AMIDE GLUCAGON SUPERFAMILY | 2011 |
|
RU2580317C2 |
| PEPTIDES FOR INHIBITING ANGIOGENESIS | 2016 |
|
RU2708375C2 |
